TRILLIUM THERAPEUTICS INC - COM NEW

CUSIP: 89620X506

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM NEW
Total 13F shares
7,011,503
Share change
-492,612
Total reported value
$42,075,379
Price per share
$6.00
Number of holders
28
Value change
-$3,789,535
Number of buys
13
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 89620X506?
CUSIP 89620X506 identifies 89620X506 - TRILLIUM THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q2 2018

As of 30 Jun 2018, TRILLIUM THERAPEUTICS INC - COM NEW was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,011,503 shares. The largest 10 holders included Matrix Capital Management Company, LP, NEA Management Company, LLC, AWM Investment Company, Inc., Cormorant Asset Management, LP, BAKER BROS. ADVISORS LP, Tekla Capital Management LLC, MORGAN STANLEY, PLATINUM INVESTMENT MANAGEMENT LTD, Artal Group S.A., and RENAISSANCE TECHNOLOGIES LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.